ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA

This adverse event was reported 61 times

ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NITAZOXANIDE 1 0.0029
1 CILTACABTAGENE AUTOLEUCEL 11 0.0017
2 ROMIDEPSIN 2 0.0012
3 IDECABTAGENE VICLEUCEL 1 0.0008
4 BRENTUXIMAB VEDOTIN 8 0.0008
5 GLUTATHIONE 1 0.0006
6 VORINOSTAT 1 0.0005
7 EPIRUBICIN HYDROCHLORIDE 2 0.0003
8 CLADRIBINE 3 0.0003
9 BENDAMUSTINE HYDROCHLORIDE 2 0.0002
See all drugs enriched for association with ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA